Moderna and other groups get $60 million to develop Ebola vaccine

(June 1, 2026) by By Jennifer Rigby, Mariam E Sunny and Julie Steenhuysen

Isomorphic Labs, which hasn’t yet disclosed a molecule or reached the clinic, breaks the recent trend of investors putting their money behind more mature and de-risked assets.

June 1 (Reuters) – Global health organisation CEPI will give roughly $60 million to Moderna (MRNA.O), opens new tab and two other groups to accelerate the development of shots ​against Ebola Bundibugyo, the deadly virus that has swept through eastern Democratic Republic of Congo.

The Coalition for Epidemic Preparedness Innovations was one of the ‌early investors that helped to develop a vaccine at the height of the COVID-19 pandemic.